Novel piperazine compound, and use thereof as HCV polymerase inhibitor

Details for Australian Patent Application No. 2007239285 (hide)

Owner Japan Tobacco Inc.

Inventors Tsuruha, Junichiro; Suma, Akira; Yokota, Masahiro; Motoda, Dai; Sugimoto, Kazuyuki; Abe, Hiroyuki; Doi, Satoki; Ueyama, Kazuhito; Iio, Kiyosei; Noguchi, Toru; Shiozaki, Makoto; Adachi, Tsuyoshi; Tanaka, Masahiro

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-B-2007239285

PCT Pub. Number WO2007/119889

Priority 2006-115008 18.04.06 JP; 60/796,565 01.05.06 US

Filing date 18 April 2007

Wipo publication date 25 October 2007

Acceptance publication date 14 April 2011

International Classifications

C07D 241/04 (2006.01) Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings

A61K 31/495 (2006.01) - having six-membered rings with two nitrogen atoms as the only ring hetero atoms, e.g. piperazine

A61K 31/496 (2006.01) - Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene

A61K 31/497 (2006.01)

A61K 31/4985 (2006.01) - Pyrazines or piperazines ortho- or peri-condensed with heterocyclic ring systems

A61K 31/501 (2006.01) - not condensed and containing further heterocyclic rings

A61K 31/5025 (2006.01) - ortho- or peri-condensed with heterocyclic ring systems

A61K 31/506 (2006.01) - not condensed and containing further heterocyclic rings

A61K 31/519 (2006.01) - ortho- or peri-condensed with heterocyclic rings

A61K 31/53 (2006.01) - having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine

A61K 31/5365 (2006.01) - ortho- or peri-condensed with heterocyclic ring systems

A61K 31/5377 (2006.01)

A61K 31/549 (2006.01) - having two or more nitrogen atoms in the same ring, e.g. hydrochlorothiazide

A61P 31/14 (2006.01) Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

A61P 43/00 (2006.01) Drugs for specific purposes, not provided for in groups

C07D 401/04 (2006.01) Heterocyclic compounds containing two or more hetero rings

C07D 401/06 (2006.01) Heterocyclic compounds containing two or more hetero rings

C07D 401/12 (2006.01) Heterocyclic compounds containing two or more hetero rings

C07D 401/14 (2006.01) Heterocyclic compounds containing two or more hetero rings

C07D 403/04 (2006.01) Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

C07D 403/06 (2006.01) Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

C07D 403/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

C07D 405/12 Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom

Event Publications

4 December 2008 PCT application entered the National Phase

  PCT publication WO2007/119889 Priority application(s): WO2007/119889

14 April 2011 Application Accepted

  Published as AU-B-2007239285

11 August 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007239311-Highly durable porous PVDF film, method of producing the same and washing method and filtration method using the same

2007239283-Activating agent for peroxisome proliferator activated receptor delta